Expect New PCSK9 Inhibitors to be Saved as Statin Add-Ons

You'll hear buzz about the "PCSK9 inhibitors" for high cholesterol, Praluent (PRAL-you-ent, alirocumab) and Repatha (ree-PATH-ah, evolocumab)....

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote